Published: July 2025
Pages: 14
Effective investigation processes are essential to identify root causes, assess product impact, implement corrective and preventive actions (CAPA), and ensure ongoing compliance with current Good Manufacturing Practices (cGMP) as required by global regulatory authorities, including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines.
This Standard Operating Procedure (SOP) includes a template to help the user outline the systematic approach to conducting investigations related to deviations, non-conformances, Out-of-Specification (OOS) results, product complaints, and other quality-related events within a pharmaceutical company’s operations.
Add all seven QMS SOP Templates to your cart and automatically unlock a 20% bundle purchase discount. View All
ISPE members located in nations with emerging economies* are eligible for a 50% discount on publications from the regular member price. To receive the discount, members must be logged in with their ISPE member account. Contact Member Services at ask@ispe.org for more information or if you have questions about your membership status or this discount program. Discounts do not apply to Accuris (formerly Techstreet) document downloads.
*Based on the World Bank's system for classifying national economies by GNI per capita. Includes low-income, lower middle-income, and upper middle-income economies. To learn more about the World Bank classification system, please click here. Currently includes the following nations, except where international sanctions apply: